Efficacy of oral losartan in recessive dystrophic epidermolysis bullosa
This article has been accepted for publication and has undergone a full review, but has not gone through the editing, layout and proofreading process; there may therefore be differences between this version and the final one.
Fig. 2: Recessive dystrophic epidermolysis bullosa in a newborn before treatment with losartan.
